Drug Interaction Studies

Inhibition assays: 1) Reversible inhibition 2) Time-dependent inhibition Metabolic Phenotype Assays: 1) CYP—chemical inhibition and recombinant enzyme methods; 2) UGT—recombinant enzyme method. Enzyme induction: CYP450 enzyme subtypes (1A2, 2B6, and 3A4) Transporter Assay: ABC transporter substrate assays (P-gp and BCRP); vesicle systems or Caco-2 cells; ABC Transporter Substrate Inhibition Assay (P-gp and BCRP): Vesicle System; SLC Transporter Substrate Assays (OATP1B1, OATP1B3, OAT1, OAT3, OCT2, MATE1, MATE2K) SLC Transporter Inhibition Assays (OATP1B1, OATP1B3, OAT1, OAT3, OCT2, MATE1, MATE2K)

Drug Interaction Studies

Inhibition experiment: 1) Reversible inhibition 2) Time-dependent inhibition

Metabolic Phenotype Assay: 1) CYP: Chemical Inhibition Method and Recombinant Enzyme Method; 2) UGT: Recombinant Enzyme Method

Enzyme induction: CYP450 enzyme subtypes (1A2, 2B6, and 3A4)

Transporter Assay:

ABC transporter substrate assays (P-gp and BCRP); vesicle systems or Caco-2 cells;

ABC Transporter Substrate Inhibition Assay (P-gp and BCRP): Vesicle System;

SLC Transporter Substrate Assays (OATP1B1, OATP1B3, OAT1, OAT3, OCT2, MATE1, MATE2K)

SLC Transporter Inhibition Assays (OATP1B1, OATP1B3, OAT1, OAT3, OCT2, MATE1, MATE2K)